Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1981 Dec;78(12):7712–7716. doi: 10.1073/pnas.78.12.7712

Increased responses to lymphokines are correlated with preleukemia in mice inoculated with Moloney leukemia virus.

J C Lee, J N Ihle
PMCID: PMC349340  PMID: 6977775

Abstract

In various mouse strains, inoculation with Moloney leukemia virus results in the establishment of an acute viremia which in most cases is followed by the induction of leukemia. Also associated with the viremia is the development of a chronic cellular immune response detectable in vitro by the ability of viral proteins to induce splenic lymphocyte proliferation. Previous studies have demonstrated that, in the absence of this cellular immune response, leukemia does not develop irrespective of whether viremia is present [Lee, J. C. & Ihle, J. N. (1981) Nature (London) 289, 407-409]. In vitro proliferative responses to antigens involve the nonspecific response of various subpopulations of lymphocytes to lymphokines produced by antigen-specific Thy 1+, Lyt 1+,2- lymphocytes. The studies presented here concern the effects of a chronic immune response in viremic mice on the frequency of lymphocytes capable of responding to lymphokines in vitro. The data demonstrate that the number of responsive lymphocytes is increased 30- to 100-fold in preleukemic mice and that such increases are dependent upon the induction of an immune response in viremic mice. The role of this altered immune response in leukemia is discussed.

Full text

PDF
7712

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berning A. K., Eicher E. M., Paul W. E., Scher I. Mapping of the X-linked immune deficiency mutation (xid) of CBA/N mice. J Immunol. 1980 Apr;124(4):1875–1877. [PubMed] [Google Scholar]
  2. Crittenden L. B., Hayward W. S., Hanafusa H., Fadly A. M. Induction of neoplasms by subgroup E recombinants of exogenous and endogenous avian retroviruses (Rous-associated virus type 60). J Virol. 1980 Feb;33(2):915–919. doi: 10.1128/jvi.33.2.915-919.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dofuku R., Biedler J. L., Spengler B. A., Old L. J. Trisomy of chromosome 15 in spontaneous leukemia of AKR mice. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1515–1517. doi: 10.1073/pnas.72.4.1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Enjuanes L., Lee J. C., Ihle J. N. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex. J Immunol. 1979 Feb;122(2):665–674. [PubMed] [Google Scholar]
  5. Enjuanes L., Lee J. C., Ihle J. N. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation. J Immunol. 1981 Apr;126(4):1478–1484. [PubMed] [Google Scholar]
  6. Hapel A. J., Lee J. C., Farrar W. L., Ihle J. N. Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3. Cell. 1981 Jul;25(1):179–186. doi: 10.1016/0092-8674(81)90242-7. [DOI] [PubMed] [Google Scholar]
  7. Ihle J. N., Pepersack L., Rebar L. Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. J Immunol. 1981 Jun;126(6):2184–2189. [PubMed] [Google Scholar]
  8. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A. 1979 May;76(5):2442–2446. doi: 10.1073/pnas.76.5.2442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lee J. C., Enjuanes L., Cicurel L., Ihle J. N. T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression. J Immunol. 1981 Jul;127(1):78–83. [PubMed] [Google Scholar]
  10. Lee J. C., Horak I., Ihle J. N. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens. J Immunol. 1981 Feb;126(2):715–722. [PubMed] [Google Scholar]
  11. Lee J. C., Ihle J. N. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71. J Immunol. 1977 Mar;118(3):928–934. [PubMed] [Google Scholar]
  12. Lee J. C., Ihle J. N. Chronic immune stimulation is required for Moloney leukaemia virus-induced lymphomas. Nature. 1981 Jan 29;289(5796):407–409. doi: 10.1038/289407a0. [DOI] [PubMed] [Google Scholar]
  13. Lee J. C., Ihle J. N. Mechanisms of C-type viral leukemogenesis. I. Correlation of in vitro lymphocyte blastogenesis to viremia and leukemia. J Immunol. 1979 Nov;123(5):2351–2358. [PubMed] [Google Scholar]
  14. McGrath M. S., Weissman I. L. AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses. Cell. 1979 May;17(1):65–75. doi: 10.1016/0092-8674(79)90295-2. [DOI] [PubMed] [Google Scholar]
  15. Smith K. A., Gilbride K. J., Favata M. F. Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature. 1980 Oct 30;287(5785):853–855. doi: 10.1038/287853a0. [DOI] [PubMed] [Google Scholar]
  16. Smith K. A., Lachman L. B., Oppenheim J. J., Favata M. F. The functional relationship of the interleukins. J Exp Med. 1980 Jun 1;151(6):1551–1556. doi: 10.1084/jem.151.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES